Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Bionime Corporation

Market Cap 4.24B 134M 116M 107M 99.97M 187M 12.75B 190M 1.26B 492M 6.21B 504M 493M 21.49B P/E Ratio 2024
-31x
P/E Ratio 2025 -22.2x
Enterprise Value 6.82B 216M 186M 172M 161M 301M 20.49B 306M 2.03B 790M 9.97B 809M 792M 34.53B EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
53.01%
Yield 2024 *
-
Yield 2025 -
1 week-0.18%
Current month-3.85%
1 month-5.34%
3 months-9.11%
6 months-0.18%
Current year-7.73%
1 week 49.75
Extreme 49.75
57
1 month 49.75
Extreme 49.75
60.6
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.1415
81.92
5 years 43.14
Extreme 43.1415
88.92
10 years 40
Extreme 40.0048
88.92
Manager TitleAgeSince
Chief Executive Officer - 09/07/2010
Director of Finance/CFO - 06/11/2017
Chief Tech/Sci/R&D Officer - 07/11/2018
Director TitleAgeSince
Chairman - 14/04/2003
Director/Board Member - 17/10/2007
Director/Board Member - 28/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.18%-18.40%-23.57% 134M
+0.55%+4.78%+167.03%+249.59% 17.45B
-1.74%-7.00%-43.82%-25.79% 9.25B
+0.19%+3.51%+34.29%+21.62% 6.8B
-0.17%+8.98% - - 5.08B
-0.39%-2.02%-27.97%-27.14% 5.06B
-2.92%-6.89%-28.74%-31.75% 4.08B
-1.36%-13.84%+68.37%+62.62% 3.77B
-0.72%-7.09%+176.91%-50.20% 3.66B
+0.64%+0.51%-16.55%-41.45% 2.64B
Average -0.59%-1.09%+34.57%+14.88% 5.79B
Weighted average by Cap. -0.45%-0.15%+63.26%+74.49%

Financials

2024 2025
Net sales 1.93B 61.15M 52.82M 48.67M 45.56M 85.38M 5.81B 86.7M 575M 224M 2.83B 230M 225M 9.8B 1.84B 58.14M 50.22M 46.28M 43.32M 81.18M 5.53B 82.44M 546M 213M 2.69B 218M 214M 9.31B
Net income -127M -4.02M -3.47M -3.2M -3M -5.62M -382M -5.7M -37.81M -14.74M -186M -15.1M -14.78M -644M -180M -5.7M -4.92M -4.54M -4.25M -7.96M -542M -8.08M -53.58M -20.89M -264M -21.4M -20.94M -913M
Net Debt 2.78B 88.04M 76.04M 70.07M 65.59M 123M 8.37B 125M 827M 323M 4.07B 330M 323M 14.1B 2.57B 81.39M 70.3M 64.78M 60.64M 114M 7.74B 115M 765M 298M 3.77B 305M 299M 13.04B
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
12/06/26 54.90 NT$ 0.00% 46,805
11/06/26 54.90 NT$ +0.18% 79,504
10/06/26 54.80 NT$ +0.37% 47,796
09/06/26 54.60 NT$ +1.68% 63,380
08/06/26 53.70 NT$ -2.36% 123,528

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!